Liquidia's (LQDA) CEO Sells 53,000 Shares for $2.1 Millionfool.comBiotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its core market.
Which Is the Better iShares Short-Term Bond ETF, IGSB or ISTB?fool.comExplore how differences in portfolio focus and risk profiles set these two core bond ETFs apart for income-minded investors.
Is Taiwan Semiconductor Manufacturing Stock a Buy on Strong AI Demand?fool.comTSMC's stock couldn't get a lift from the strong outlook in its latest earnings report.
The Catalyst Is Coming. Here's Why Smart Investors Are Buying United Parcel Service Before June 30.fool.comThe third quarter begins in July, and UPS' management believes it will mark the inflection point for the turnaround.
UWM Holdings' (UWMC) CEO Sells 2 Million Shares for $7.5 Millionfool.comAmerica’s largest wholesale mortgage lender reported a notable insider sale amid a year of declining share prices.
4 Consumer Staples Stocks Built to Outlast Any Market Downturnfool.comInvestors who are worried about the future can look to these stable and predictable businesses.
What Replaced the Medicare "Donut Hole," and How It's Likely to Impact Youfool.comYou may be surprised to learn how much you can personally benefit from the closing of the donut hole.
2 Under-the-Radar Biotech Stocks Worth Buying for the Long Termfool.comVertex Pharmaceuticals has given Mirum Pharmaceuticals the blueprint for success in rare diseases.
Weekend Round-Up: Binance Rivals Major Exchanges, Bitcoin's Million-Dollar Potential And Morebenzinga.comThis week, crypto buzzed with Binance growth, $1M Bitcoin calls, Ethereum bets, Dogecoin buying, and political tensions.
Which Is the Better Vanguard Short-Term Bond ETF, BSV or VGSH?fool.comExplore how each ETF’s unique bond mix shapes risk and diversification for short-term investors weighing safety versus broader exposure.
Don't Write Off Claiming Social Security at 62fool.comYou'll slash your benefits, but there's much more to the story.
Is State Street's SPLB ETF's Corporate Bond Focus the Better Choice Over iShares TLT's U.S. Treasuries?fool.comExplore how differing bond exposures and cost structures set these two long-term ETFs apart for income-focused portfolios.
Medicare Won't Cover These Costs. Here's How to Prepare for Them.fool.comNew retirees may be surprised by how many medical expenses they'll have to pay out of pocket.
Dianthus Therapeutics' (DNTH) CFO Sold 8,224 Shares for $739,000fool.comThis clinical-stage biotech focused on monoclonal antibody therapies reported a notable insider sale in its latest SEC filing.
